Introduction {#bjs10600-sec-0005}
============

Randomized trial evidence has shown that, in men, abdominal aortic aneurysm (AAA) screening reduces AAA‐related mortality (relative risk reduction 42 (95 per cent c.i. 31 to 51) per cent)[1](#bjs10600-bib-0001){ref-type="ref"}, and is highly cost‐effective[2](#bjs10600-bib-0002){ref-type="ref"}. As a result, AAA screening in men aged 65 years was fully implemented across England and Wales in 2013, and is now established across the UK. In historical studies, screening for AAA in women has not been demonstrated to be clinically effective, although the only randomized trial was underpowered[3](#bjs10600-bib-0003){ref-type="ref"}.

Recent reanalysis of economic models of AAA screening in men has demonstrated that it remains highly cost‐effective[2](#bjs10600-bib-0002){ref-type="ref"} despite reductions in disease prevalence[4](#bjs10600-bib-0004){ref-type="ref"}, [5](#bjs10600-bib-0005){ref-type="ref"}, and that the prevalence threshold for cost‐effectiveness in men is lower than the historical estimates of disease prevalence in older women[6](#bjs10600-bib-0006){ref-type="ref"}. Approximately one in seven elective AAA repairs in England and Wales are performed on women[7](#bjs10600-bib-0007){ref-type="ref"}, and women account for one‐third of all deaths from ruptured AAA[8](#bjs10600-bib-0008){ref-type="ref"}. Together with a fourfold higher rupture rate in women than men at equivalent aortic diameters[9](#bjs10600-bib-0009){ref-type="ref"}, [10](#bjs10600-bib-0010){ref-type="ref"}, this suggests that there may be a strong case for the initiation of AAA screening in women, or selected high‐risk groups of women.

An important determinant of the effectiveness of any screening programme is the risk associated with treatment. For AAA screening, it cannot be assumed that this risk (the risk of AAA repair) is the same for women as for men. Sex differences in vascular surgical outcomes have been described[11](#bjs10600-bib-0011){ref-type="ref"}, [12](#bjs10600-bib-0012){ref-type="ref"}, and case series[13](#bjs10600-bib-0013){ref-type="ref"}, [14](#bjs10600-bib-0014){ref-type="ref"} have shown differences after AAA repair, with women exposed to a higher perioperative risk[15](#bjs10600-bib-0015){ref-type="ref"}. However, no large studies have been able to explore the reasons for these differences or adjust for co‐variables. Excess perioperative risk in women[16](#bjs10600-bib-0016){ref-type="ref"} may offset any advantage gained by preventing rupture, and would also have a negative impact on the cost‐effectiveness of any screening programme to identify women with AAA. Yet, many of the data used to compare the risks of surgery between men and women are dated, and are limited by the modest representation of women in studies of AAA. Furthermore, past studies have contained inadequate detail to determine whether any differences observed are confounded by patient characteristics.

The aim of this study was to quantify differences in in‐hospital mortality between women and men undergoing AAA repair in the UK National Health Service (NHS) using data obtained from the National Vascular Registry (NVR), which allows adjustment for relevant co‐variables, such as smoking and AAA diameter, and the Hospital Episode Statistics (HES) data set.

Methods {#bjs10600-sec-0006}
=======

National Vascular Registry {#bjs10600-sec-0007}
--------------------------

The NVR was established to measure the quality and outcomes of care for patients who undergo major vascular surgery in NHS hospitals, and was commissioned by the Healthcare Quality Improvement Partnership as part of the National Clinical Audit and Patient Outcomes Programme[17](#bjs10600-bib-0017){ref-type="ref"}. Data are assessed using consistency and range checks, as well as comparison with HES data. NHS Trusts in England are duty‐bound to provide HES data for financial probity[17](#bjs10600-bib-0017){ref-type="ref"}. Case ascertainment, which is the number of cases input to the NVR compared with that estimated from HES, was 84 per cent in 2012--2014 for elective AAA repair and 75 per cent for ruptured AAA repair[7](#bjs10600-bib-0007){ref-type="ref"}. The NVR is the largest validated registry of admissions to NHS hospitals for AAA repair, and includes cases from Northern Ireland, Scotland and Wales as well as England[18](#bjs10600-bib-0018){ref-type="ref"}.

Anonymized individual patient‐level data from the NVR for patients who underwent AAA repair in the UK between January 2010 and December 2014 were obtained under a data‐sharing agreement with the Healthcare Quality Improvement Partnership. Patients with elective and ruptured AAA were included; symptomatic AAA, duplicate data and patients who presented with alternative diagnoses (acute aortic dissection, chronic aortic dissection or aortic transection) were excluded. Patients who underwent an operation other than endovascular aneurysm repair (EVAR) or open repair (complex EVAR, open revision or EVAR revision) were also excluded. Complex open AAA repairs were not included, nor were any records that did not record the sex of the patient.

Operation type is recorded at the time of operation in the NVR according to the OPCS‐4 codes, in addition to a number of supplementary procedure options to differentiate infrarenal, juxtarenal and suprarenal aneurysms. Any juxtarenal or suprarenal AAA is classified as a complex aneurysm.

National Vascular Registry variables included {#bjs10600-sec-0008}
---------------------------------------------

Demographic co‐variables available were age and sex. Preoperative clinical co‐variables available were AAA diameter, co‐morbidities (diabetes, hypertension, chronic obstructive pulmonary disease, ischaemic heart disease, heart failure, chronic renal failure and stroke), smoking status and indication for operation. Postoperative co‐variables were level 3 admission (high‐dependency unit or ICU), duration of stay in critical care and in hospital, and death (in‐hospital mortality only) (*Appendix S1* [S1](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information).

Hospital Episode Statistics analysis {#bjs10600-sec-0009}
------------------------------------

HES is the administrative data set for the NHS in England, which contains information regarding patient admission to NHS hospitals. HES data are anonymized by the allocation of a unique anonymous identifier to each patient, so individuals can be tracked through admissions to different hospitals. HES was analysed for all infrarenal AAA repairs (excluding those under cardiac or cardiothoracic surgery specialties) for procedures performed between 1 January 2010 and 31 December 2014 in order to match the NVR analysis.

The algorithm for identifying cases utilized a modified version of a previously published methodology[19](#bjs10600-bib-0019){ref-type="ref"}. It was based on an iterative process in which a group of clinicians looked at the records of a sample of cases with potentially ambiguous codes (such as L188, L189) and, by inspecting the associated diagnostic and specialty codes, determined the most likely categorization, for example AAA. This included the codes for aortoiliac bypass where there is an associated diagnostic code of AAA (I171).

Clinical review of coding showed that the emergency codes (L194 *versus* L184) were not used accurately, and that HES coding systems do not accurately differentiate between acute admission for symptomatic aneurysms and ruptured aneurysm. Therefore, a set of decision rules was developed to establish a proxy classification by which to identify ruptured aneurysms. Admissions were classified as ruptured AAA, on the basis of the coding of method of admission; those with any EVAR code (L271--L289) were classified as EVAR, and emergency admissions where the date of the first procedure was the day of admission were assumed to represent cases of ruptured AAA. One weakness of the NVR is that it is a self‐reported data set and open to bias. The reason for including a comparable analysis based on HES data within this article was to demonstrate that the differences in the NVR are not unique to this registry and may therefore represent real differences in outcomes. It also allowed the authors to cross‐check that the number of deaths recorded in the NVR and HES were comparable.

Study design {#bjs10600-sec-0010}
------------

The primary outcome measure was in‐hospital mortality for men and women by indication and operation type calculated from NVR data. NVR‐based outcomes were checked against HES data. Secondary outcome measures included mortality by 5‐year age groups, and duration of stay.

Statistical analysis {#bjs10600-sec-0011}
--------------------

Summary statistics are presented by sex using mean(s.d.) for continuous, non‐skewed data and median (i.q.r.) for skewed data. Categorical data are presented as counts and percentages. Differences in characteristics between men and women were assessed using the Mann--Whitney *U* test for all continuous co‐variables and χ^2^ test for categorical variables.

The risk of death in hospital was modelled using logistic regression separately for elective open repair, elective EVAR, emergency open repair and emergency EVAR. The odds ratio (OR) for sex was first estimated for each operation type without adjustment for any other characteristics. Potential confounding of the sex effect was then investigated by adjusting for age, calendar year of operation, AAA diameter and smoking status. These co‐variables were chosen because of their excellent data completeness within the NVR, and only individuals with complete data on all the adjustment variables in that model were retained. In a sensitivity analysis, further adjustment was made for the occurrence of each co‐morbidity recorded in the NVR using available data. Individuals with missing information on any co‐variable were excluded from these analyses. All continuous variables were assumed to act linearly on the log odds. The numbers reported are affected by the extent of missing data. Wald tests were used to obtain two‐sided *P* values for the estimated log ORs. All statistical analyses were completed using R version 3.2.4 (R Project for Statistical Computing, Vienna, Austria) and SPSS® version 22.0 (IBM, Armonk, New York, USA).

Results {#bjs10600-sec-0012}
=======

National Vascular Registry data {#bjs10600-sec-0013}
-------------------------------

Between January 2010 and December 2014, some 23 245 patients underwent elective or ruptured AAA repair (EVAR or open) in the UK and had outcomes reported to the NVR.

### Elective surgical repair {#bjs10600-sec-0014}

In all, 18 693 patients had elective AAA repair, of whom 16 465 (88·1 per cent) were men. At any age, proportionally fewer women than men underwent EVAR compared with open surgical repair (*Fig*. [1](#bjs10600-fig-0001){ref-type="fig"}). Although the use of EVAR increased progressively in older age groups, it decreased with larger aneurysm diameter (*Table* [1](#bjs10600-tbl-0001){ref-type="table-wrap"}, supporting information). The duration of hospital stay was longer in women than in men after elective EVAR and open AAA repair. The time spent in critical care was longer in women after open AAA repair (*Table* [1](#bjs10600-tbl-0001){ref-type="table-wrap"}).

![Overall proportion of elective abdominal aortic aneurysm operations that are endovascular aneurysm repair (EVAR), with 95 per cent confidence intervals, by sex and age](BJS-104-1656-g002){#bjs10600-fig-0001}

###### 

Characteristics and outcomes for elective open and endovascular abdominal aortic aneurysm repair

                                                                                  Open repair         EVAR                                                                                                                
  ------------------------------------------------------------------------------- ------------------- --------------------- -------------------------------------------------- -------------------- --------------------- --------------------------------------------------
  UK National Vascular Registry                                                   922                 6013                                                                     1306                 10 452                
  Age (years)[\*](#bjs10600-note-0001a){ref-type="fn"}                            74·1(7·7)           71·5(7·6)             \< 0·001[§](#bjs10600-note-0003){ref-type="fn"}    78·4(7·1)            76·0(7·6)             \< 0·001[§](#bjs10600-note-0003){ref-type="fn"} 
                                                                                  (n = 922)           (n = 6012)                                                               (n = 1306)           (n = 10 452)          
  AAA diameter (mm)[†](#bjs10600-note-0001b){ref-type="fn"}                       60 (56--67)         62 (57--72)           \< 0·001[§](#bjs10600-note-0003){ref-type="fn"}    59 (56--65)          60 (57--67)           \< 0·001[§](#bjs10600-note-0003){ref-type="fn"} 
                                                                                  (n = 877)           (n = 5796)                                                               (n = 1227)           (n = 9849)            
  Co‐morbidities                                                                                                                                                                                                          
  Diabetes                                                                        94 of 372 (25·3)    702 of 2735 (25·7)    0·921                                              139 of 615 (22·6)    1636 of 5293 (30·9)   \< 0·001  
  Hypertension                                                                    149 of 372 (40·1)   1192 of 2735 (43·6)   0·221                                              307 of 615 (49·9)    2165 of 5293 (40·9)   \< 0·001  
  COPD                                                                            66 of 372 (17·7)    347 of 2735 (12·7)    0·009                                              121 of 615 (19·7)    810 of 5293 (15·3)    0·006
  IHD                                                                             132 of 372 (35·5)   1074 of 2735 (39·3)   0·183                                              232 of 615 (37·7)    2512 of 5293 (47·5)   \< 0·001  
  Heart failure                                                                   13 of 372 (3·5)     109 of 2735 (4·0)     0·752                                              45 of 615 (7·3)      451 of 5293 (8·5)     0·351
  Renal failure                                                                   32 of 372 (8·6)     152 of 2735 (5·6)     0·027                                              82 of 615 (13·3)     510 of 5293 (9·6)     0·005
  Stroke                                                                          26 of 372 (7·0)     141 of 2735 (5·2)     0·181                                              25 of 615 (4·1)      272 of 5293 (5·1)     0·293
  Current smoker                                                                  285 of 878 (32·5)   1467 of 5780 (25·4)   \< 0·001                                           246 of 1197 (20·6)   1577 of 9600 (16·4)   \< 0·001  
  Duration of critical care stay (days)[†](#bjs10600-note-0001b){ref-type="fn"}   3 (2--5)            2 (1--4)               0·021[§](#bjs10600-note-0003){ref-type="fn"}      1 (0--1)             1 (0--1)               0·005[§](#bjs10600-note-0003){ref-type="fn"}
  (n = 471)                                                                       (n = 3188)                                (n = 504)                                          (n = 3677)                                 
  Duration of hospital stay (days)[†](#bjs10600-note-0001b){ref-type="fn"}        9 (7--13)           8 (6--11)             \< 0·001[§](#bjs10600-note-0003){ref-type="fn"}    4 (2--6)             3 (2--5)              \< 0·001[§](#bjs10600-note-0003){ref-type="fn"} 
  (n = 922)                                                                       (n = 6013)                                (n = 1306)                                         (n = 10 452)                               
  In‐hospital death                                                               64 of 922 (6·9)     243 of 6013 (4·0)     \< 0·001                                           23 of 1306 (1·8)     74 of 10 452 (0·7)    \< 0·001  
  HES -- England                                                                                                                                                                                                          
  In‐hospital death                                                               64 of 1066 (6·0)    213 of 6832 (3·1)     \< 0·001                                           27 of 1642 (1·6)     104 of 13 070 (0·8)   \< 0·001

Values in parentheses are percentages unless indicated otherwise; values are

mean(s.d.) and

median (i.q.r.).

EVAR, endovascular aneurysm repair; AAA, abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; HES, Hospital Episode Statistics.

χ^2^ test, except

Mann--Whitney U test.

Some 6935 patients underwent elective open surgical repair. Women were older (mean 74·1 versus 71·5 years) and more likely to smoke (32·5 versus 25·4 per cent). The in‐hospital mortality rate was 6·9 per cent in women compared with 4·0 per cent in men (OR 1·77, 95 per cent c.i. 1·33 to 2·35; P \< 0·001) (Fig. [2](#bjs10600-fig-0002){ref-type="fig"} and Table [2](#bjs10600-tbl-0002){ref-type="table-wrap"}). Stratification by age group demonstrated an increase in mortality rate with age (Table [S2](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information). After adjustment, the sex difference in mortality remained significant (OR 1·48, 1·08 to 2·02; P = 0·014) (Table [2](#bjs10600-tbl-0002){ref-type="table-wrap"}).

![In‐hospital mortality for elective abdominal aortic aneurysm repair, with 95 per cent confidence intervals, by sex. EVAR, endovascular aneurysm repair](BJS-104-1656-g003){#bjs10600-fig-0002}

###### 

Logistic regression analyses of in‐hospital mortality for women versus men after elective abdominal aortic aneurysm repair

  Type of repair   Data source       Unadjusted       Adjusted[\*](#bjs10600-note-0004a){ref-type="fn"}                                          
  ---------------- ------------- ------------------- --------------------------------------------------- ---------- -------- ------------------- ------------
  Open repair      NVR                  6935                          1·77 (1·33, 2·35)                   \< 0·001    6408    1·48 (1·08, 2·02)     0·014
  HES              7898           1·98 (1·49, 2·65)                       \< 0·001                                                               
  EVAR             NVR                 11 758                         2·51 (1·57, 4·03)                   \< 0·001   10 165   2·86 (1·72, 4·74)   \< 0·001  
  HES              14 712         2·08 (1·36, 3·19)                       \< 0·001                                                               

Values in parentheses are 95 per cent confidence intervals. Odds ratios are shown for women *versus* men.

Adjusted for age, calendar year, abdominal aortic aneurysm diameter and smoking status. NVR, National Vascular Registry; HES, Hospital Episode Statistics; EVAR, endovascular aneurysm repair.

A total of 11 758 patients underwent elective (non‐complex) EVAR. The women were older than the men (mean 78·4 *versus* 76·0 years). More women were hypertensive (49·9 *versus* 40·9 per cent) or a smoker (20·6 *versus* 16·4 per cent), whereas more men were diabetic (30·9 *versus* 22·6 per cent) or had ischaemic heart disease (47·5 *versus* 37·7 per cent). The in‐hospital mortality rate was 1·8 per cent in women and 0·7 per cent in men (OR 2·51, 1·57 to 4·03; *P* \< 0·001) (*Fig*. [2](#bjs10600-fig-0002){ref-type="fig"} and *Table* [2](#bjs10600-tbl-0002){ref-type="table-wrap"}), and increased with age (*Table* [S2](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information). The sex difference was similar after adjustment for age, smoking status, AAA diameter and calendar year (OR 2·86, 1·72 to 4·74; *P* \< 0·001) (*Table* [2](#bjs10600-tbl-0002){ref-type="table-wrap"}). After further adjustment (sensitivity analysis) for co‐morbidities, the estimated sex differences were of the same or greater magnitude, although the confidence intervals were wider owing to considerable missing co‐morbidity data (*Table* [S3](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information).

### Ruptured aneurysm repair {#bjs10600-sec-0015}

A total of 4552 patients underwent surgery for a ruptured AAA, of whom 3767 were men (82·8 per cent). The majority (81·1 per cent) underwent open repair (*Table* [3](#bjs10600-tbl-0003){ref-type="table-wrap"}); among these, women were older (mean 77·7 *versus* 74·8 years) and had smaller aneurysm diameters (median 72 *versus* 80 mm), whereas more men had diabetes (26·6 *versus* 16·4 per cent). There was no difference between men and women in duration of stay in hospital or critical care after rupture. The proportion of women undergoing a ruptured AAA repair was higher than the proportion undergoing elective repair.

###### 

Characteristics and outcomes for ruptured open and endovascular abdominal aortic aneurysm repair

                                                                                  Open repair         EVAR                                                                                                             
  ------------------------------------------------------------------------------- ------------------- --------------------- -------------------------------------------------- ------------------ -------------------- --------------------------------------------------
  UK National Vascular Registry                                                   653                 3037                                                                     132                730                  
  Age (years)[\*](#bjs10600-note-0005a){ref-type="fn"}                            77·7(7·1)           74·8(7·9)             \< 0·001[§](#bjs10600-note-0007){ref-type="fn"}    79·8(8·6)          77·4(8·7)             0·002[§](#bjs10600-note-0007){ref-type="fn"}
  (*n* = 653)                                                                     (*n* = 3037)                              (*n* = 132)                                        (*n* = 730)                             
  AAA diameter (mm)[†](#bjs10600-note-0005b){ref-type="fn"}                       72 (60--80)         80 (70--90)           \< 0·001[§](#bjs10600-note-0007){ref-type="fn"}    69 (60--80)        77 (64--90)          \< 0·001[§](#bjs10600-note-0007){ref-type="fn"} 
  (*n* = 286)                                                                     (*n* = 1503)                              (*n* = 122)                                        (*n* = 648)                             
  Co‐morbidities                                                                                                                                                                                                       
  Diabetes                                                                        44 of 269 (16·4)    350 of 1318 (26·6)    \< 0·001                                           18 of 71 (25)      79 of 396 (19·9)     0·872
  Hypertension                                                                    131 of 269 (48·7)   507 of 1318 (38·5)    0·002                                              35 of 71 (49)      179 of 396 (45·2)    0·614
  COPD                                                                            46 of 269 (17·1)    181 of 1318 (13·7)    0·184                                              16 of 71 (23)      83 of 396 (21·0)     0·893
  IHD                                                                             93 of 269 (34·6)    506 of 1318 (38·4)    0·271                                              29 of 71 (41)      184 of 396 (46·5)    0·465
  Heart failure                                                                   14 of 269 (5·2)     67 of 1318 (5·1)      1·000                                              9 of 71 (13)       42 of 396 (10·6)     0·762
  Renal failure                                                                   25 of 269 (9·3)     92 of 1318 (7·0)      0·231                                              11 of 71 (15)      55 of 396 (13·9)     0·861
  Stroke                                                                          21 of 269 (7·8)     103 of 1318 (7·8)     1·000                                              5 of 71 (7)        37 of 396 (9·3)      0·691
  Current smoker                                                                  178 of 591 (30·1)   786 of 2693 (29·2)    0·693                                              27 of 125 (21·6)   163 of 662 (24·6)    0·543
  Duration of critical care stay (days)[†](#bjs10600-note-0005b){ref-type="fn"}   5 (2--8)            4 (2--10)              0·952[§](#bjs10600-note-0007){ref-type="fn"}      2 (1--4)           2 (1--4)              0·644[§](#bjs10600-note-0007){ref-type="fn"}
  (*n* = 286)                                                                     (*n* = 1503)                              (*n* = 62)                                         (*n* = 394)                             
  Duration of hospital stay (days)[†](#bjs10600-note-0005b){ref-type="fn"}        12 (3--23)          11 (5--21)             0·861[§](#bjs10600-note-0007){ref-type="fn"}      9 (4--17)          8 (4--16)             0·621[§](#bjs10600-note-0007){ref-type="fn"}
  (*n* = 653)                                                                     (*n* = 3017)                              (*n* = 132)                                        (*n* = 730)                             
  In‐hospital death                                                               260 of 653 (39·8)   1120 of 3037 (36·9)   0·172                                              33 of 132 (25·0)   151 of 730 (20·7)    0·321
  HES -- England                                                                                                                                                                                                       
  In‐hospital death                                                               284 of 845 (33·6)   1109 of 4089 (27·1)   \< 0·001                                           31 of 244 (12·7)   148 of 1276 (11·6)   0·612

Values in parentheses are percentages unless indicated otherwise; values are

mean(s.d.) and

median (i.q.r.).

EVAR, endovascular aneurysm repair; AAA, abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; HES, Hospital Episode Statistics.

χ^2^ test, except

Mann--Whitney *U* test.

The in‐hospital mortality rate after open repair of ruptured AAA was 39·8 per cent in women and 36·9 per cent in men (OR 1·13, 95 per cent c.i. 0·95 to 1·35; *P* = 0·161) (*Fig*. [3](#bjs10600-fig-0003){ref-type="fig"} and *Table* [4](#bjs10600-tbl-0004){ref-type="table-wrap"}), and increased with age (*Table* [S4](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information). The sex difference remained non‐significant after adjustment (*Table* [4](#bjs10600-tbl-0004){ref-type="table-wrap"}).

![In‐hospital mortality for ruptured abdominal aortic aneurysm repair, with 95 per cent confidence intervals, by sex. EVAR, endovascular aneurysm repair](BJS-104-1656-g001){#bjs10600-fig-0003}

###### 

Logistic regression analyses of in‐hospital mortality for women versus men after ruptured abdominal aortic aneurysm repair

  Type of repair   Data source   Unadjusted          Adjusted[\*](#bjs10600-note-0008a){ref-type="fn"}                                      
  ---------------- ------------- ------------------- --------------------------------------------------- ------- ------ ------------------- -------
  Open repair      NVR           3690                1·13 (0·95, 1·35)                                   0·161   2975   0·91 (0·75, 1·12)   0·382
  HES              4934          1·36 (1·16, 1·59)   \< 0·001                                                                               
  EVAR             NVR           862                 1·28 (0·83, 1·97)                                   0·272   713    1·50 (0·92, 2·44)   0·112
  HES              1520          1·11 (0·73, 1·68)   0·621                                                                                  

Values in parentheses are 95 per cent confidence intervals. Odds ratios are shown for women *versus* men.

Adjusted for age, calendar year, abdominal aortic aneurysm diameter and smoking status. NVR, National Vascular Registry; HES, Hospital Episode Statistics; EVAR, endovascular aneurysm repair.

For ruptured EVAR, the in‐hospital mortality rate was 25·0 per cent in women *versus* 20·7 per cent in men (OR 1·28, 0·83 to 1·97; *P* = 0·272) (*Tables* [3](#bjs10600-tbl-0003){ref-type="table-wrap"} and [4](#bjs10600-tbl-0004){ref-type="table-wrap"}) and AAA diameter was smaller in women than men. A sex difference in mortality was not evident after adjustment for age, smoking status, AAA diameter and calendar year (*Table* [4](#bjs10600-tbl-0004){ref-type="table-wrap"}), or after further adjustment (sensitivity analysis) for co‐morbidities (*Table* [S3](#bjs10600-supitem-0001){ref-type="supplementary-material"}, supporting information).

Hospital Episode Statistics {#bjs10600-sec-0016}
---------------------------

HES data for the same calendar period as the NVR analyses also provided evidence of sex differences for outcomes after elective AAA repair. For open AAA repair, the in‐hospital mortality rate in HES was 6·0 per cent for women and 3·1 per cent for men (OR 1·98, 95 per cent c.i. 1·49 to 2·65; *P* \< 0·001) (*Tables* [1](#bjs10600-tbl-0001){ref-type="table-wrap"} and [2](#bjs10600-tbl-0002){ref-type="table-wrap"}), similar to NVR data. For elective EVAR, the HES mortality rates were 1·6 per cent in women and 0·8 per cent in men (OR 2·08, 1·36 to 3·19; *P* \< 0·001), again similar to NVR data.

For ruptured AAA, the HES data demonstrated a greater in‐hospital mortality rate in women compared with men (33·6 *versus* 27·1 per cent; OR 1·36, 1·16 to 1·59; *P* \< 0·001) after open AAA repair, but not for EVAR (OR 1·11, 0·73 to 1·68; *P* = 0·621) (*Tables* [3](#bjs10600-tbl-0003){ref-type="table-wrap"} and [4](#bjs10600-tbl-0004){ref-type="table-wrap"}).

Discussion {#bjs10600-sec-0017}
==========

This contemporary study suggests that women undergoing elective AAA repair in the UK have an approximately twofold higher in‐hospital mortality rate after either open repair or EVAR in both the NVR and HES data sets. In previous work[14](#bjs10600-bib-0014){ref-type="ref"}, this group identified differences between men and women in elective AAA outcomes, but was unable to explore the reasons for these differences or adjust for co‐variables. In the present study, the excess mortality risk in elective AAA repair was demonstrated to be largely independent of age, aneurysm diameter, smoking status and calendar time. Furthermore, sensitivity analysis, in which further adjustment was made for co‐morbidities, continued to support the sex differences seen, mostly after elective EVAR. Although the sex differences identified may have a negative impact on any future screening in women, further studies are needed.

Female sex has previously been associated with increased mortality risk after AAA repair. For example, in an analysis of data from the American College of Surgeons National Surgical Improvement Program (2011--2014), Deery and co‐workers[20](#bjs10600-bib-0020){ref-type="ref"} similarly demonstrated that women undergoing elective AAA repair were older, had smaller aneurysms, and had a higher mortality rate (30 day) after EVAR (3·2 *versus* 1·2 per cent) and open AAA repair (8·0 *versus* 4·0 per cent). Egorova and colleagues[21](#bjs10600-bib-0021){ref-type="ref"} analysed the Medicare population (1995--2006), noting perioperative mortality rates after elective open repair of 6·4 per cent for women (compared with 6·9 per cent in the present cohort) and 3·0 per cent for women undergoing elective EVAR (compared with 1·8 per cent here).

Mehta and colleagues[22](#bjs10600-bib-0022){ref-type="ref"} also demonstrated that elective EVAR carries a greater risk of death in women than men (3·2 *versus* 1·0 per cent; *P* \< 0·005) although in their series no sex difference was found among those undergoing open repair. Similarly, Abedi *et al*.[23](#bjs10600-bib-0023){ref-type="ref"} described higher mortality rates in women following elective EVAR (3·4 *versus* 2·1 per cent; *P* = 0·01), in addition to higher morbidity rates (17·8 *versus* 10·6 per cent; *P* \< 0·001), which included a composite of 21 postoperative adverse events[24](#bjs10600-bib-0024){ref-type="ref"}. Taken together, these findings highlight a higher postoperative risk for women after elective AAA repair.

There is currently no consensus on the role of screening for AAA in women and, to date, there has been only one small randomized trial of screening in women[3](#bjs10600-bib-0003){ref-type="ref"}; this did not show any mortality benefit, although it was underpowered. The excess elective mortality in women identified in the present study in addition to an increased duration of stay may erode some of the potential benefit from screening in women, although one‐third of all deaths from AAA rupture in England are now in women[8](#bjs10600-bib-0008){ref-type="ref"}, and the poor outcomes identified in this study after emergency AAA repair (which are similar for women and men) may still favour AAA screening in women. In an evaluation of the cost‐effectiveness of screening 65‐year‐old women, Wanhainen and colleagues[25](#bjs10600-bib-0025){ref-type="ref"} found that the incremental cost--effectiveness ratio was similar to that for screening men; however, contemporary data on this are required.

Other parameters that may relate to an increased mortality risk in women undergoing AAA repair include more complex arterial anatomy and occult cardiovascular disease. Aneurysm morphology has been shown to differ between the sexes in several small cohort studies; women are more likely to have shorter, more angulated infrarenal necks[26](#bjs10600-bib-0026){ref-type="ref"} and small iliac arteries[27](#bjs10600-bib-0027){ref-type="ref"}, [28](#bjs10600-bib-0028){ref-type="ref"}, [29](#bjs10600-bib-0029){ref-type="ref"}, [30](#bjs10600-bib-0030){ref-type="ref"}, making EVAR more challenging. For ruptured AAA, the aneurysm necks are often shorter and more angulated in women, rendering most unsuitable for EVAR[31](#bjs10600-bib-0031){ref-type="ref"}. These morphological factors may explain the lower utilization of EVAR in women in the present study and may also partially explain the worse outcomes in women. The Canadian Society for Vascular Surgery Aneurysm Study Group[32](#bjs10600-bib-0032){ref-type="ref"} identified that women were more likely to be older, have a positive family history of AAA, and have significant aortoiliac occlusive disease. In the era of EVAR, the diameter of the iliac axis and possible aortoiliac occlusive disease play a major role in the technical success of the procedure[33](#bjs10600-bib-0033){ref-type="ref"}. A detailed analysis of a population undergoing AAA repair, with known coexisting co‐morbid factors and well characterized anatomy before surgery, is required to assess the precise interactions of sex and other parameters on subsequent mortality after AAA repair.

It is difficult to suggest specific strategies to improve mortality in women undergoing AAA repair, given that the exact reasons for their poorer outcome remain unknown. Similar findings have been demonstrated in the USA, suggesting that this is not a problem specific to the NHS. It may be that a quality improvement project is required to improve outcomes in women after elective AAA repair. One suggestion may be the routine use of adjuncts such as cardiopulmonary exercise testing (CPET) to quantify risk in women undergoing AAA repair and guide aggressive preoperative optimization. CPET may be performed safely in high‐risk populations and is a recognized reliable measure of cardiovascular reserve in patients undergoing major surgery, such as open AAA repair[34](#bjs10600-bib-0034){ref-type="ref"}. Patients classified as high risk based on CPET can then be optimized before operation by means of a variety of strategies, in order to improve their cardiovascular reserve, including commencement of high‐dose statin therapy, antiplatelet treatment, better control of hypertension by adding extra agents, lifestyle advice including smoking cessation, weight loss, correction of anaemia, and improved control of diabetes. Another suggestion might be the design of endografts more suitable for women.

For ruptured open AAA repair, which includes the majority of ruptures, the NVR data suggested no difference in hospital mortality (*P* = 0·161) whereas the HES data suggested a higher mortality rate among women (OR 1·36, 95 per cent c.i. 1·16 to 1·59; *P* \< 0·001), although these data were unadjusted. This difference remains unexplained, although it may reflect bias in reporting ruptured AAA repairs to the NVR as the case ascertainment for such cases is only 75 per cent[7](#bjs10600-bib-0007){ref-type="ref"}. It is also interesting to note that the median AAA diameter reported at the time of repair of ruptured AAA is about 1 cm smaller in women than men. One unknown in the NVR and HES cohorts is the turn‐down rate for elective or ruptured AAA repair, which would influence the true mortality rate. In a retrospective cohort study from England[35](#bjs10600-bib-0035){ref-type="ref"}, the turn‐down rate was 13 per cent (mostly secondary to medical co‐morbidity), with women being more likely to be turned down (OR 11·26, 95 per cent c.i. 3·96 to 31·99; *P* \< 0·001). Similarly, Ulug and co‐workers[36](#bjs10600-bib-0036){ref-type="ref"} demonstrated that turn‐down rates were higher in women than men (34 *versus* 19 per cent; OR 2·27, 1·21 to 4·23), compared with 9·2 per cent within the first 5 years of the NHS Abdominal Aortic Aneurysm Screening Programme (men only)[37](#bjs10600-bib-0037){ref-type="ref"}.

Although these data suggest that differences exist between women and men undergoing AAA repair in the UK, it does not suggest that AAA screening in women would not be beneficial. The ongoing National Institute for Health Research (NIHR) trial of AAA screening of women in Leicestershire and Northamptonshire (Female Aneurysm Screening Study) and the ongoing Health Technology Assessment (HTA)‐funded modelling study to examine the potential clinical benefit and cost‐effectiveness of AAA screening in women (Screening Women for abdominal aortic Aneurysms; SWAN study) will add the much‐needed context of these findings to any possible AAA screening in women. Although the NVR is the largest validated registry of AAA repairs performed in the UK, some patients are not entered in the database, which raises the possibility of bias. By analysing the HES data set separately, the authors have demonstrated that the in‐hospital mortality rate differs between men and women for elective repairs in both the NVR and HES, suggesting that reporting bias does not explain the differences seen. One limitation of using the HES data set to assess rupture is the difficulty in separating ruptured aneurysms from symptomatic AAAs requiring urgent surgery. However, a modified version of a previously published algorithm[19](#bjs10600-bib-0019){ref-type="ref"} for analysing HES data was used here, which relies on admission method and day of surgery to separate these different pathologies with different inherent risks.

Not all fields within the NVR are mandatory and some data fields were missing; for example, co‐morbidity data were missing in approximately half of the NVR data set. This deficiency of the NVR has now been addressed in that co‐morbidity data are better captured. The sensitivity analysis demonstrated similar ORs after adjustment for co‐morbidities, but with wider confidence intervals, which is to be expected owing to the amount of missing data. Only a well designed trial of matched women and men undergoing elective AAA repair would truly explain the differences seen. However, even after further adjustment, the present study continues to support the finding of sex differences in mortality.

In this study, patients were excluded from specific analyses where data were not available. The NVR was established as part of the National Clinical Audit and Patient Outcomes Programme[17](#bjs10600-bib-0017){ref-type="ref"} and HES is the administrative data set for the NHS in England. These data sets are not primarily designed for research, and therefore the quality of the data within this observational study may be poor.
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